Cargando…

Testing the validity of national drug surveys: comparison between a general population cohort and household surveys

BACKGROUND AND AIMS: There are concerns that national population‐based estimates of illicit drug use are underestimated. We investigated this by comparing estimates of illicit substance use at age 24 from the Crime Survey for England and Wales (CSEW) with a birth cohort (Avon Longitudinal Study of P...

Descripción completa

Detalles Bibliográficos
Autores principales: Charles, Hannah, Heron, Jon, Hickman, Matthew, Brown, Jamie, Hines, Lindsey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359398/
https://www.ncbi.nlm.nih.gov/pubmed/33455031
http://dx.doi.org/10.1111/add.15371
_version_ 1783737541102403584
author Charles, Hannah
Heron, Jon
Hickman, Matthew
Brown, Jamie
Hines, Lindsey
author_facet Charles, Hannah
Heron, Jon
Hickman, Matthew
Brown, Jamie
Hines, Lindsey
author_sort Charles, Hannah
collection PubMed
description BACKGROUND AND AIMS: There are concerns that national population‐based estimates of illicit drug use are underestimated. We investigated this by comparing estimates of illicit substance use at age 24 from the Crime Survey for England and Wales (CSEW) with a birth cohort (Avon Longitudinal Study of Parents and Children, ALSPAC) and by comparing the Smoking and Alcohol Toolkit Studies (STS/ATS) to ALSPAC. DESIGN: Cross‐sectional household survey and cross‐sectional data from one wave of a longitudinal birth cohort. SETTING: England and Wales. PARTICIPANTS: Young adults aged 23–25 reporting on substance use in 2017 to CSEW (n = 1165), ALSPAC (n = 3389) and STS/ATS (n = 950). MEASUREMENTS: Lifetime and past‐year illicit drug use, smoking status and hazardous drinking at age 24. FINDINGS: The 2017 CSEW estimate of lifetime illicit drug use was 40.6%, compared with 62.8% in ALSPAC (risk difference % [RD%] = 22.2%; 95% CI = 18.9–25.5%; P ≤ 0.001). The RD in lifetime use between ALSPAC and the CSEW was 23.2% (95% CI = 20.0–26.4%) for cannabis, 16.9% (95% CI = 14.4–19.4%) for powder cocaine and 24.8% (95% CI = 22.6–27.0%) for amphetamine. Past‐year drug use was 16.4% in CSEW, compared with 36.7% in ALSPAC (RD% = 20.3%; 95% CI = 17.6–23.0%; P ≤ 0.001). For past‐year substance use, the RD between ALSPAC and the CSEW was 15.4% (95% CI = 12.9–17.9%) for cannabis, 14.8% (95% CI = 13.0%–16.6%) for powder cocaine and 15.9% (95% CI = 14.5–17.4%) for amphetamine. Levels of current smoking were similar between STS (27.4%) and ALSPAC (29.4%). Hazardous drinking was substantially higher in ALSPAC (60.3%) than the ATS (32.1%; RD% = 28.2%; 95% CI = 24.8–31.6%; P ≤ 0.001). CONCLUSIONS: The Avon Longitudinal Study of Parents and Children provides one source of validation for measurements of drug use in government household surveys and indicates that illicit drug use may be underestimated in the Crime Survey for England and Wales.
format Online
Article
Text
id pubmed-8359398
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83593982021-08-17 Testing the validity of national drug surveys: comparison between a general population cohort and household surveys Charles, Hannah Heron, Jon Hickman, Matthew Brown, Jamie Hines, Lindsey Addiction Research Reports BACKGROUND AND AIMS: There are concerns that national population‐based estimates of illicit drug use are underestimated. We investigated this by comparing estimates of illicit substance use at age 24 from the Crime Survey for England and Wales (CSEW) with a birth cohort (Avon Longitudinal Study of Parents and Children, ALSPAC) and by comparing the Smoking and Alcohol Toolkit Studies (STS/ATS) to ALSPAC. DESIGN: Cross‐sectional household survey and cross‐sectional data from one wave of a longitudinal birth cohort. SETTING: England and Wales. PARTICIPANTS: Young adults aged 23–25 reporting on substance use in 2017 to CSEW (n = 1165), ALSPAC (n = 3389) and STS/ATS (n = 950). MEASUREMENTS: Lifetime and past‐year illicit drug use, smoking status and hazardous drinking at age 24. FINDINGS: The 2017 CSEW estimate of lifetime illicit drug use was 40.6%, compared with 62.8% in ALSPAC (risk difference % [RD%] = 22.2%; 95% CI = 18.9–25.5%; P ≤ 0.001). The RD in lifetime use between ALSPAC and the CSEW was 23.2% (95% CI = 20.0–26.4%) for cannabis, 16.9% (95% CI = 14.4–19.4%) for powder cocaine and 24.8% (95% CI = 22.6–27.0%) for amphetamine. Past‐year drug use was 16.4% in CSEW, compared with 36.7% in ALSPAC (RD% = 20.3%; 95% CI = 17.6–23.0%; P ≤ 0.001). For past‐year substance use, the RD between ALSPAC and the CSEW was 15.4% (95% CI = 12.9–17.9%) for cannabis, 14.8% (95% CI = 13.0%–16.6%) for powder cocaine and 15.9% (95% CI = 14.5–17.4%) for amphetamine. Levels of current smoking were similar between STS (27.4%) and ALSPAC (29.4%). Hazardous drinking was substantially higher in ALSPAC (60.3%) than the ATS (32.1%; RD% = 28.2%; 95% CI = 24.8–31.6%; P ≤ 0.001). CONCLUSIONS: The Avon Longitudinal Study of Parents and Children provides one source of validation for measurements of drug use in government household surveys and indicates that illicit drug use may be underestimated in the Crime Survey for England and Wales. John Wiley and Sons Inc. 2021-01-17 2021-08 /pmc/articles/PMC8359398/ /pubmed/33455031 http://dx.doi.org/10.1111/add.15371 Text en © 2021 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Reports
Charles, Hannah
Heron, Jon
Hickman, Matthew
Brown, Jamie
Hines, Lindsey
Testing the validity of national drug surveys: comparison between a general population cohort and household surveys
title Testing the validity of national drug surveys: comparison between a general population cohort and household surveys
title_full Testing the validity of national drug surveys: comparison between a general population cohort and household surveys
title_fullStr Testing the validity of national drug surveys: comparison between a general population cohort and household surveys
title_full_unstemmed Testing the validity of national drug surveys: comparison between a general population cohort and household surveys
title_short Testing the validity of national drug surveys: comparison between a general population cohort and household surveys
title_sort testing the validity of national drug surveys: comparison between a general population cohort and household surveys
topic Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359398/
https://www.ncbi.nlm.nih.gov/pubmed/33455031
http://dx.doi.org/10.1111/add.15371
work_keys_str_mv AT charleshannah testingthevalidityofnationaldrugsurveyscomparisonbetweenageneralpopulationcohortandhouseholdsurveys
AT heronjon testingthevalidityofnationaldrugsurveyscomparisonbetweenageneralpopulationcohortandhouseholdsurveys
AT hickmanmatthew testingthevalidityofnationaldrugsurveyscomparisonbetweenageneralpopulationcohortandhouseholdsurveys
AT brownjamie testingthevalidityofnationaldrugsurveyscomparisonbetweenageneralpopulationcohortandhouseholdsurveys
AT hineslindsey testingthevalidityofnationaldrugsurveyscomparisonbetweenageneralpopulationcohortandhouseholdsurveys